Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I

NCT02402530 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

459

Enrollment

INDUSTRY

Sponsor class

Conditions

Complex Regional Pain Syndrome, Type I

Interventions

DRUG: Placebo
DRUG: Neridronic acid 62.5 mg

Sponsor

Grünenthal GmbH